We recently demonstrated a reduced rate of catheter-related infection (CRI) when using silver sulphadiazine and chlorhexidine impregnated central venous catheters (CVC) compared with standard non-impregnated CVCs 1 , a finding concurring with previous studies 2-4 . The current study was conducted as part of a national multicentre survey to determine whether the use of the antiseptic-impregnated catheters (AIC) reduced the CRI rate and catheterrelated bacteraemia (CRB) rate, when compared to the use of standard non-impregnated catheters (SC). In addition to these aims, we further analysed the cumulative CRI rate versus the dwell time (time from insertion to removal).
We recently demonstrated a reduced rate of catheter-related infection (CRI) when using silver sulphadiazine and chlorhexidine impregnated central venous catheters (CVC) compared with standard non-impregnated CVCs 1 , a finding concurring with previous studies [2] [3] [4] . The current study was conducted as part of a national multicentre survey to determine whether the use of the antiseptic-impregnated catheters (AIC) reduced the CRI rate and catheterrelated bacteraemia (CRB) rate, when compared to the use of standard non-impregnated catheters (SC). In addition to these aims, we further analysed the cumulative CRI rate versus the dwell time (time from insertion to removal).
METHODS
One hundred and fifty-one patients who had 196 CVCs placed while in the ICU during the ten-month survey period were included in the survey. Institutional ethics committee approval was granted to carry out audit of CVC usage in the ICU.
All CVCs were placed either in the internal jugular vein or the subclavian vein using the aseptic technique previously described 1 . The standard (SC) nonimpregnated triple lumen polyurethane CVC (Arrow International Inc., Pennsylvania, U.S.A.) and the silver sulphadiazine and chlorhexidine impregnated (AIC) CVC (Arrowgard Blue, Arrow International Inc., Pennsylvania, U.S.A.) were alternated for use in the ICU on a bimonthly basis. The two types of CVC are identical in dimension. No other CVCs were used during the survey period.
Demographic data, including age and APACHE II scores, were collected for all patients requiring a CVC. The dwell time was recorded in days. CVCs were removed as per clinical indications, i.e. either when they were no longer needed for monitoring or therapy, or if catheter-related infection was suspected. Upon removal, the CVC tips were sent for The overall rate of CVC tip infection was lower in the impregnated CVC group (15.6% vs 30.9%, P<0.05). The impregnated CVC group had a much lower cumulative infection rate when the dwell time in patients was five days or less (3.3% vs 26.9%, P<0.05). However, the difference between the cumulative infection rate was not statistically significant (P>0.05) for dwell times of 6, 7 or 8 days respectively. There was no difference in the CVC related bacteraemia rates between the two groups (3.9% vs 3.7%, P>0.05).
culture using the technique and criteria described by Maki and co-workers 5 . The outcome end-points surveyed included rate of CVC tip culture positivity and bacteraemia rate. Catheter-related infection (CRI) was defined as a positive catheter tip culture. Catheter-related bacteraemia (CRB) was defined as the simultaneous isolation of the same organism from the catheter tip and peripheral blood culture 6 .
Blood cultures were taken only when clinically indicated-a rise in white cell count (above 11,000 per cubic millimetre or a 25% increase from baseline), the presence of a pyrexia greater than 38.5°C or an inflamed CVC skin exit site. Blood for these cultures was drawn aseptically from a vein and 10 ml injected into one each of the aerobic and anaerobic culture bottles (Bactec, Becton Dickinson and Co., MD, U.S.A.). The specimens were immediately transported to the laboratory where they were incubated at 37°C for five days. They were then plated out and identified according to standard laboratory practice.
Statistical Analysis
Unpaired t tests, Wilcoxon signed rank, Chisquared (with Yates' correction as appropriate) and
Fisher's exact test were used. A P value of less than 0.05 was considered significant.
RESULTS
A total of 196 consecutive CVC insertions in 151 patients in the ICU were surveyed over the tenmonth period. After excluding 38 CVCs in 26 patients that were not sent for culture, we had a final number of 158 CVC insertions in 125 patients. The demographic features of the survey groups (antiseptic impregnated CVC group-AIC, standard nonimpregnated CVC group-SC) are comparable ( Table 1 ).
The dwell time for both groups had a similar frequency distribution (Figure 1 ) and the mean dwell time for both groups are comparable (P>0.5) when the standard error of difference between means is calculated.
The AIC group showed a statistically significant lower overall CRI rate compared with the SC group (P<0.05, Table 1 ).
The cumulative incidence of CRI for a particular dwell time-incidence of CRI in all CVCs that were inserted for the period of less than and including the dwell time is represented for both groups in Figure 2 . For dwell time of five days or less, the cumulative CRI rate in the AIC group was markedly lower (3.3% vs 26.9% for SC group, P<0.05). Although the cumulative CRI rate was also lower for dwell time of 638 S. LOO, P. V. VAN up to 6, 7 and 8 days respectively, these were not statistically significant. This difference in the CRI rate became statistically significant again, however, for dwell times of up to 9, 10, 11 and 12 days respectively. Of the 11 episodes where there were concurrent positive CVC tip cultures and positive blood cultures, only six episodes fulfilled the CRB criteria of having the same organism isolated from both sources, threeepisodes in each of the study groups (AIC vs SC: 3.9% vs 3.7%, P>0.05).
DISCUSSION
The data in Table 1 indicate the comparability of the two groups of patients in this survey. Figure 1 also illustrates the comparability of the distribution of dwell time in both groups. The current survey continues to support the findings of a lower overall CRI rate in patients receiving antiseptic-impregnated CVCs ( Table I) .
The cumulative incidence of CRI with respect to dwell time was analysed to allow a time-based comparison of the two groups. We assume that if a catheter tip is infected at a particular dwell time, it would remain infected even if it were removed after a longer dwell time. The true clinically significant CRI incidence at any dwell time should therefore be the cumulative CRI for catheters removed on or before that dwell time.
This study's AIC group demonstrated maximal advantage over the SC group in terms of significantly lower cumulative CRI rate for dwell time of up to five days ( Figure 2 ). We therefore recommend that AIC should probably be the choice of catheter when the expected dwell time is not more than five days. It is interesting that the difference between the cumulative CRI rates was not statistically significant for dwell times of up to 6, 7 and 8 days respectively, but became statistically significant again for dwell times of up to 9, 10, 11 and 12 days. Limited by the size and design of this study, we are not able to make definite conclusions regarding this re-emergence of statistical significance. It may be spurious, a result of the small number of catheters that had dwell time of more than eight days. However, we cannot discount the possibility of a real trend in subgroups of patients that have decreased CRI risks for AIC catheters at longer dwell times of 9 to 12 days. It would be useful to conduct an appropriately designed study to ascertain such subgroups.
There was no difference in the CRB rates between the two groups in this study. This may be due to the size of our sample population as our results approximate those of Trazzera 3 (AIC vs SC: 3.28% vs 4.6%, P=not significant) where the total sample size was similar (n=181). Maki 2 was able to demonstrate a lower CRB rate (AIC vs SC: 1.0% vs 4.7%, P=0.005) with a larger sample size of 405.
CONCLUSIONS
This study supports the finding of a lower overall rate of catheter-related infection in silver sulphadiazine and chlorhexidine impregnated CVCs compared with the standard catheters (15.6% vs 30.9%, P<0.05). The impregnated catheters also showed maximal advantage in terms of markedly lower cumulative CRI rates when placed for up to five days (3.3% vs 26.9%, P<0.05). Given the small sample size, we were unable to demonstrate a lower catheter-related bacteraemia rate in the antiseptic-impregnated group.
